Suppr超能文献

循环肿瘤细胞技术

Circulating tumor cell technologies.

作者信息

Ferreira Meghaan M, Ramani Vishnu C, Jeffrey Stefanie S

机构信息

Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.

Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Mol Oncol. 2016 Mar;10(3):374-94. doi: 10.1016/j.molonc.2016.01.007. Epub 2016 Jan 28.

Abstract

Circulating tumor cells, a component of the "liquid biopsy", hold great potential to transform the current landscape of cancer therapy. A key challenge to unlocking the clinical utility of CTCs lies in the ability to detect and isolate these rare cells using methods amenable to downstream characterization and other applications. In this review, we will provide an overview of current technologies used to detect and capture CTCs with brief insights into the workings of individual technologies. We focus on the strategies employed by different platforms and discuss the advantages of each. As our understanding of CTC biology matures, CTC technologies will need to evolve, and we discuss some of the present challenges facing the field in light of recent data encompassing epithelial-to-mesenchymal transition, tumor-initiating cells, and CTC clusters.

摘要

循环肿瘤细胞作为“液体活检”的一个组成部分,在改变当前癌症治疗格局方面具有巨大潜力。要发挥循环肿瘤细胞的临床应用价值,一个关键挑战在于能否使用适合下游特征分析及其他应用的方法来检测和分离这些稀有细胞。在本综述中,我们将概述目前用于检测和捕获循环肿瘤细胞的技术,并简要介绍各项技术的工作原理。我们重点关注不同平台所采用的策略,并讨论每种策略的优势。随着我们对循环肿瘤细胞生物学的理解不断成熟,循环肿瘤细胞技术也需要不断发展,我们将根据最近有关上皮-间质转化、肿瘤起始细胞和循环肿瘤细胞簇的数据,讨论该领域目前面临的一些挑战。

相似文献

1
Circulating tumor cell technologies.
Mol Oncol. 2016 Mar;10(3):374-94. doi: 10.1016/j.molonc.2016.01.007. Epub 2016 Jan 28.
2
Technologies for circulating tumor cell separation from whole blood.
J Hematol Oncol. 2019 May 14;12(1):48. doi: 10.1186/s13045-019-0735-4.
4
Microfilter-Based Capture and Release of Viable Circulating Tumor Cells.
Methods Mol Biol. 2017;1634:93-105. doi: 10.1007/978-1-4939-7144-2_7.
5
Size-based enrichment technologies for CTC detection and characterization.
Recent Results Cancer Res. 2012;195:87-95. doi: 10.1007/978-3-642-28160-0_8.
8
EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Oncol Rep. 2017 Jan;37(1):77-82. doi: 10.3892/or.2016.5235. Epub 2016 Nov 8.
9
Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.
Methods Mol Biol. 2017;1634:193-202. doi: 10.1007/978-1-4939-7144-2_16.
10
Circulating tumor cells: a multifunctional biomarker.
Clin Cancer Res. 2014 May 15;20(10):2553-68. doi: 10.1158/1078-0432.CCR-13-2664.

引用本文的文献

1
The Quest for Non-Invasive Diagnosis: A Review of Liquid Biopsy in Glioblastoma.
Cancers (Basel). 2025 Aug 19;17(16):2700. doi: 10.3390/cancers17162700.
3
Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer.
Cancer Med. 2025 Jun;14(11):e70902. doi: 10.1002/cam4.70902.
4
Label-Free and Rapid Microfluidic Design Rules for Circulating Tumor Cell Enrichment and Isolation: A Review and Simulation Analysis.
ACS Omega. 2025 Feb 11;10(7):6306-6322. doi: 10.1021/acsomega.4c08606. eCollection 2025 Feb 25.
5
Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumors.
J Liq Biopsy. 2024 Nov 14;6:100275. doi: 10.1016/j.jlb.2024.100275. eCollection 2024 Dec.
6
Clinical significance of genomic sequencing of circulating tumour cells (CTCs) in cancer.
J Liq Biopsy. 2023 Dec 28;3:100135. doi: 10.1016/j.jlb.2023.100135. eCollection 2024 Mar.
7
Role of Cell Adhesion in Cancer Metastasis Formation: A Review.
ACS Omega. 2025 Feb 9;10(6):5193-5213. doi: 10.1021/acsomega.4c08140. eCollection 2025 Feb 18.
9
New Horizons of Biomarkers in Metastatic Thyroid Cancer.
J Cancer. 2025 Jan 1;16(1):241-264. doi: 10.7150/jca.101395. eCollection 2025.

本文引用的文献

1
Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.
Cancer Res. 2015 Nov 15;75(22):4681-7. doi: 10.1158/0008-5472.CAN-15-1633. Epub 2015 Oct 15.
2
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
Nature. 2015 Oct 1;526(7571):131-5. doi: 10.1038/nature15260. Epub 2015 Sep 23.
3
Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.
Expert Rev Mol Diagn. 2015;15(11):1411-7. doi: 10.1586/14737159.2015.1091729. Epub 2015 Sep 21.
4
Acoustofluidic, label-free separation and simultaneous concentration of rare tumor cells from white blood cells.
Anal Chem. 2015 Sep 15;87(18):9322-8. doi: 10.1021/acs.analchem.5b02023. Epub 2015 Sep 3.
5
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
Front Oncol. 2015 Jul 20;5:155. doi: 10.3389/fonc.2015.00155. eCollection 2015.
6
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings.
J Am Coll Surg. 2015 Sep;221(3):699-707. doi: 10.1016/j.jamcollsurg.2015.05.014. Epub 2015 May 27.
7
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.
Oncotarget. 2015 Jun 20;6(17):15578-93. doi: 10.18632/oncotarget.3903.
8
EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Oncotarget. 2015 May 10;6(13):10697-711. doi: 10.18632/oncotarget.4037.
9
A microfluidic device for label-free, physical capture of circulating tumor cell clusters.
Nat Methods. 2015 Jul;12(7):685-91. doi: 10.1038/nmeth.3404. Epub 2015 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验